Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > HORIBA Medical and CEA-Leti Strengthen Their Partnership to Develop Tomorrow’s Diagnostics at the Point of Care

Abstract:
HORIBA Medical, a subsidiary of Japan-based HORIBA Group, the global leader for measurement and analysis systems, has been designing, manufacturing and marketing high performance analyzers for laboratories and hospitals for over 30 years. This expertise that has made the company one of the world leaders in Hematology and a key player in the Hemostasis and Clinical Chemistry activity.

HORIBA Medical and CEA-Leti Strengthen Their Partnership to Develop Tomorrow’s Diagnostics at the Point of Care

Montpellier and Grenoble, France | Posted on July 21st, 2020

Today, patient care and treatment practices are evolving quickly. HORIBA Medical is designing solutions to anticipate patient-centered needs by developing new POCT (Point of Care Testing) systems.



In parallel, for the past six years HORIBA Medical has been working with one of the most innovative organizations in the field of new technologies, CEA-Leti, the technology research laboratory of CEA Tech, federating their respective skills in a Joint Laboratory called HEMACOUNT.



“We focused on two disruptive technologies: a microfluidic cartridge and a new, lens-free imaging device (LensFree), which will enable development of more compact, easier-to-use POCT-type devices,” says Damien Isebe, who heads up this highly innovative project at HORIBA Medical. “Twelve families of patents have been filed since the start of the project, and the latest one has been the subject of several scientific papers”.



“Flow cytometry is the main analytical technology in hematology, but it requires large and complex hardware systems. Conversely, lens-free imaging combined with a sample prepared as a microfluidic cartridge paves the way to a simple and compact disruptive architecture. This imaging technique provides a wide field of view (≈30mm˛) resulting in a counting statistic (a few thousand cells) in one single acquisition consistent with required hematological performance,” explains Sophie Morales, laboratory head at CEA-Leti.



The latest publications and presentations to date: for LensFree, one publication in the Journal of Biomedical Optics and two oral presentations at ECBO (European Conferences on Biomedical Optics), held in Munich in late June 2019; and for the work on microfluidics, presentation of a scientific poster at µTAS (International Conference on Miniaturized Systems for Chemistry and Life Sciences) in Basel, Switzerland, in October 2019.



Given the success of the partnership and the work that remains to be done, HORIBA Medical is pleased to announce the continuation of this collaboration, which will allow it to draw value from this work in the form of innovative applications, to bring developments to maturity and to design products that will serve care-givers and patients.



Patents: DD17052- FR1663028: “Procedure for counting particles in a sample by lens-free imaging”

####

About Leti
Leti, a technology research institute at CEA, is a global leader in miniaturization technologies enabling smart, energy-efficient and secure solutions for industry. Founded in 1967, CEA-Leti pioneers micro-& nanotechnologies, tailoring differentiating applicative solutions for global companies, SMEs and startups. CEA-Leti tackles critical challenges in healthcare, energy and digital migration. From sensors to data processing and computing solutions, CEA-Leti’s multidisciplinary teams deliver solid expertise, leveraging world-class pre-industrialization facilities. With a staff of more than 1,900, a portfolio of 3,100 patents, 10,000 sq. meters of cleanroom space and a clear IP policy, the institute is based in Grenoble, France, and has offices in Silicon Valley and Tokyo. CEA-Leti has launched 65 startups and is a member of the Carnot Institutes network. Follow us on www.leti-cea.com and @CEA_Leti.

About HORIBA Medical

HORIBA Medical offers an extensive and comprehensive line of hematology, coagulation and clinical chemistry solutions (including reagents) for in vitro diagnostics. The HORIBA Medical brand has earned the trust of a wide customer base through the quality and reliability of its products. Today, over 30,000 laboratories around the world use HORIBA Medical solution (more information at: www.horiba.com).

For more information, please click here

Contacts:
Press Contact HORIBA Medical

Carole Barascud

Public and Media Relations



Tel. +33.4.67.14.15.59



Press Contact CEA-Leti

Agency

Tel. +33 6 74 93 23 47

Copyright © Leti

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

When Dirac meets frustrated magnetism August 3rd, 2020

New printing process advances 3D capabilities: Technology aims to improve quality of products used in business, industry and at home July 31st, 2020

TU Graz researchers synthesize nanoparticles tailored for special applications July 31st, 2020

Scientists discover new class of semiconducting entropy-stabilized materials July 31st, 2020

Chemistry

Way, shape and form: Synthesis conditions define the nanostructure of manganese dioxide July 31st, 2020

Study: Mapping crystal shapes could fast-track 2D materials: Experts call for global effort to clear hurdles to mass production July 27th, 2020

Imaging

Bruker Launches Revolutionary High-Speed AFM System for Single-Molecule Applications: JPK NanoRacer® Follows Molecular Dynamics in Real Time at 50 Frames per Second July 30th, 2020

Study: Mapping crystal shapes could fast-track 2D materials: Experts call for global effort to clear hurdles to mass production July 27th, 2020

Scientists open new window into the nanoworld July 17th, 2020

Possible Futures

Physicists find misaligned carbon sheets yield unparalleled properties July 31st, 2020

Way, shape and form: Synthesis conditions define the nanostructure of manganese dioxide July 31st, 2020

New printing process advances 3D capabilities: Technology aims to improve quality of products used in business, industry and at home July 31st, 2020

Scientists discover new class of semiconducting entropy-stabilized materials July 31st, 2020

Nanomedicine

Izon Science receives $10.5M investment from Bolton Equities: Christchurch-headquartered nanotech company secures investment to accelerate global growth; appoints top board chairman and directors July 28th, 2020

Arrowhead Pharmaceuticals Hosts Key Opinion Leader Webinar on ARO-ENaC for Treatment of Cystic Fibrosis July 28th, 2020

Silver-plated gold nanostars detect early cancer biomarkers: New optical sensing platform can detect genomic cancer biomarkers directly in patient tissues July 24th, 2020

Charcoal a weapon to fight superoxide-induced disease, injury: Nanomaterials soak up radicals, could aid treatment of COVID-19 July 2nd, 2020

Discoveries

When Dirac meets frustrated magnetism August 3rd, 2020

Way, shape and form: Synthesis conditions define the nanostructure of manganese dioxide July 31st, 2020

New printing process advances 3D capabilities: Technology aims to improve quality of products used in business, industry and at home July 31st, 2020

TU Graz researchers synthesize nanoparticles tailored for special applications July 31st, 2020

Announcements

When Dirac meets frustrated magnetism August 3rd, 2020

New printing process advances 3D capabilities: Technology aims to improve quality of products used in business, industry and at home July 31st, 2020

TU Graz researchers synthesize nanoparticles tailored for special applications July 31st, 2020

Scientists discover new class of semiconducting entropy-stabilized materials July 31st, 2020

Patents/IP/Tech Transfer/Licensing

A new study published on the cover of Science could bolster the development of batteries, fuel cells, 3D printing technologies and more May 1st, 2020

New green technology from UMass Amherst generates electricity 'out of thin air' Renewable device could help mitigate climate change, power medical devices February 17th, 2020

The Wave of the Future: Researchers achieve first successful generation and detection of pure spin currents in antiferromagnetic materials January 29th, 2020

Supercharging tomorrow: Monash develops world's most efficient lithium-sulfur battery January 3rd, 2020

Nanobiotechnology

Izon Science receives $10.5M investment from Bolton Equities: Christchurch-headquartered nanotech company secures investment to accelerate global growth; appoints top board chairman and directors July 28th, 2020

Arrowhead Pharmaceuticals Hosts Key Opinion Leader Webinar on ARO-ENaC for Treatment of Cystic Fibrosis July 28th, 2020

Silver-plated gold nanostars detect early cancer biomarkers: New optical sensing platform can detect genomic cancer biomarkers directly in patient tissues July 24th, 2020

Charcoal a weapon to fight superoxide-induced disease, injury: Nanomaterials soak up radicals, could aid treatment of COVID-19 July 2nd, 2020

Research partnerships

Discovery of disordered nanolayers in intermetallic alloys: Resolving alloys' strength-ductility trade-off and thermal instability July 24th, 2020

Russian scientists identified energy storage mechanism of sodium-ion battery anode July 24th, 2020

'Blinking" crystals may convert CO2 into fuels: Unusual nanoparticles could benefit the quest to build a quantum computer July 17th, 2020

Scientists open new window into the nanoworld July 17th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project